E Vilmer

12.4k total citations · 2 hit papers
132 papers, 7.4k citations indexed

About

E Vilmer is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, E Vilmer has authored 132 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Hematology, 40 papers in Public Health, Environmental and Occupational Health and 37 papers in Immunology. Recurrent topics in E Vilmer's work include Acute Lymphoblastic Leukemia research (38 papers), Acute Myeloid Leukemia Research (18 papers) and Hematopoietic Stem Cell Transplantation (18 papers). E Vilmer is often cited by papers focused on Acute Lymphoblastic Leukemia research (38 papers), Acute Myeloid Leukemia Research (18 papers) and Hematopoietic Stem Cell Transplantation (18 papers). E Vilmer collaborates with scholars based in France, Belgium and United States. E Vilmer's co-authors include C Griscelli, Alain Fischer, Françoise Le Deist, Christine Rouzioux, Stéphane Blanche, Jean‐Claude Chermann, Françoise Barré‐Sinoussi, Luc Montagnier, Bernard Grandchamp and Albert Faye and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

E Vilmer

129 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Selective Tropism of Lymphadenopathy Associated Virus (LAV) for Helper-Inducer T Lymphocytes

1984 807 citations E Vilmer, Christine Rouzioux et al. profile →
Munc13-4 Is Essential for Cytolytic Granules Fusion and Is Mutated in a Form of Familial Hemophagocytic Lymphohistiocytosis (FHL3)

2003 684 citations Nathalie Lambert, Gaëlle Chédeville et al. profile →

Peers

Countries citing papers authored by E Vilmer

Since Specialization

Citations

This map shows the geographic impact of E Vilmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Vilmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Vilmer more than expected).

Fields of papers citing papers by E Vilmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Vilmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Vilmer. The network helps show where E Vilmer may publish in the future.

Co-authorship network of co-authors of E Vilmer

This figure shows the co-authorship network connecting the top 25 collaborators of E Vilmer. A scholar is included among the top collaborators of E Vilmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Vilmer. E Vilmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Should TPMT genotype and activity be used to monitor 6-mercaptopurine treatment in children with acute lymphoblastic leukaemia? 2007 ·Journal of Clinical Pharmacy and Therapeutics ·May Fakhoury, (unknown), Alfred Mahr, Yves Médard, (unknown), E Vilmer, Évelyne Jacqz-Aigrain	20
2	Listing of Common HLA Alleles and Haplotypes Based on the Study of 356 Families Residing in the Paris, France, Area: Implications for Unrelated Hematopoietic Stem Cell Donor Selection 2005 ·Human Immunology ·(unknown), Karima Yakouben, Dalila Adjaoud, Anne Auvrignon, Judith Landman, Valérie Guérin, Guy Leverger, E Vilmer, Ghislaine Sterkers	25
3	Post-Transplant Lymphoproliferative Disorder in Children 2005 ·Pediatric Drugs ·Albert Faye, E Vilmer	32
4	Incidence of childhood leukaemia and non-Hodgkinʼs lymphoma in France: National Registry of Childhood Leukaemia and Lymphoma, 1990–1999 2004 ·European Journal of Cancer Prevention ·Jacqueline Clavel, A Goubin, Marie-Françoise Auclerc, Anne Auvrignon, C Waterkeyn, Catherine Patte, André Baruchel, Guy Leverger, Brigitte Nelken, N Philippe, D. Sommelet, E Vilmer, Stéphanie Bellec, F. Ménégaux, Denis Hémon	84
5	Acute childhood leukaemia and environmental exposure to potential sources of benzene and other hydrocarbons; a case-control study 2004 ·Occupational and Environmental Medicine ·Christoph A. Steffen, Marie-Françoise Auclerc, Anne Auvrignon, André Baruchel, Kamila Kébaïli, Anne Lambilliotte, G Leverger, D. Sommelet, E Vilmer, (unknown), Jacqueline Clavel	109
6	Autoimmune Lymphoproliferative Syndrome with SomaticFasMutations 2004 ·New England Journal of Medicine ·(unknown), Cédric Vonarbourg, Marie‐Claude Stolzenberg, Peter D. Arkwright, Françoise Selz, (unknown), Stéphane Blanche, Jiřina Bartůňková, E Vilmer, Alain Fischer, Françoise Le Deist, Frédéric Rieux‐Laucat	224
7	Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study 2002 ·The Lancet ·Isabelle André‐Schmutz, Françoise Le Deist, Salima Hacein‐Bey‐Abina, Ellen S. Vitetta, John Schindler, Gaëlle Chédeville, E Vilmer, Alain Fischer, Marina Cavazzana	168
8	Early multitherapy including a protease inhibitor for human immunodeficiency virus type 1-infected infants 2002 ·The Pediatric Infectious Disease Journal ·Albert Faye, (unknown), Jean Paul Teglas, Marie‐Laure Chaix, (unknown), Ghislaine Firtion, Isabelle Thuret, Catherine Dollfus, Fabrice Monpoux, Corinne Floch, (unknown), E Vilmer, Christine Rouzioux, (unknown), Stéphane Blanche	38
9	Quantification of TEL–AML1 transcript for minimal residual disease assessment in childhood acute lymphoblastic leukaemia 2001 ·British Journal of Haematology ·Séverine Drunat, Martine Olivi, (unknown), Bernard Grandchamp, E Vilmer, Ivan Bièche, Hélène Cavé	19
10	Analgésie contrôlée par le patient dans la douleur prolongée de l'enfant. Étude ouverte prospective de faisabilité d'une méthode standardisée 2000 ·Archives de Pédiatrie ·M. Duval, Fanny Legrand, Albert Faye, (unknown), (unknown), Pierre‐Simon Rohrlich, Chantal Wood, (unknown), E Vilmer	3
11	Mapping of chromosome 20 for loss of heterozygosity in childhood ALL reveals a 1000-kb deletion in one patient 1999 ·Leukemia ·Nathalie Couque, (unknown), Hélène Cavé, Valérie Bardet, Michel Duval, E Vilmer, Bernard Grandchamp	2
12	Chediak-Higashi syndrome associated with maternal uniparental isodisomy of chromosome 1 1999 ·European Journal of Human Genetics ·Rémi Dufourcq-Lagelouse, Nathalie Lambert, Michel Duval, Géraldine Viot, E Vilmer, Alain Fischer, Marguerite Prieur, Geneviève de Saint Basile	40
13	[Idiopathic thrombopenic purpura in a child in black Africa: a case report in Togo]. 1998 ·PubMed ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), E Vilmer, (unknown)	0
14	In VivoInfusion of Anti-LFA-1 and Anti-CD2 Antibodies Prevents Graft Failure After HLA Partially Incompatible Bone Marrow Transplantation in Children with High Risk Acute Lymphoblastic Leukaemia 1997 ·Leukemia & lymphoma ·Marina Cavazzana, Nada Jabado, Pierre Bordigoni, Gérard Michel, Élie Haddad, Françoise Méchinaud, Judith Landman‐Parker, (unknown), E Plouvier, André Baruchel, JL Stéphan, G Souillet, E Vilmer, John Wijdenes, F Le Deist, Alain Fischer	5
15	ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia 1997 ·Leukemia ·Hélène Cavé, V. Cacheux, Sophie Raynaud, (unknown), Marleen Bâkkus, Pascale Cochaux, Claude Preudhomme, JL Laï, E Vilmer, Bernard Grandchamp	84
16	Heterogeneity of B Lineage Acute Lymphoblastic Leukemias (B-ALL) with Regard to their in Vitro Spontaneous Proliferation, Growth Factor Response and BCL-2 Expression 1996 ·Leukemia & lymphoma ·(unknown), Urszula Hibner, E Vilmer, Claude Baillou, Pierre‐Simon Rohrlich, Dominique Heymann, A Najman, M Guigon, François M. Lemoine	10
17	Mitoxantrone-containing regimen for treatment of childhood acute leukemia AML and analysis of prognostic factors: Results of the EORTC Children Leukemia Cooperative Study 58872 1996 ·Medical and Pediatric Oncology ·C Béhar, Stefan Suciu, Yves Benoît, Alain Robert, E Vilmer, Patrick Boutard, Y Bertrand, Patrick Lutz, A. Ferster, (unknown), Anne‐Marie Manel, G. Solbu, Jacques Otten	19
18	Chromosome 6p rearrangements appear to be secondary changes in various haematological malignancies 1989 ·Leukemia Research ·J. L. Huret, (unknown), A. Brizard, François Guilhot, E Vilmer, J Tanzer	9
19	Immune recognition of AIDS virus antigens by human and murine cytotoxic T lymphocytes. 1988 ·The Journal of Immunology ·Pierre Langlade‐Demoyen, Frédérique Michel, A Hoffenbach, E Vilmer, Gilles Dadaglio, (unknown), C Mayaud, Brigitte Autran, Simon Wain–Hobson, Fernando Plata	39
20	Predominant expression of circulating CD3+ lymphocytes bearing gamma T cell receptor in a prolonged immunodeficiency after allogeneic bone marrow transplantation. 1988 ·Journal of Clinical Investigation ·E Vilmer, P Guglielmi, Violaine David, Gérald Leca, C. Rabian, L Degos, M Boiron, Armand Bensussan	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact